Autopsy report · NCT02905201

A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

“The protocol was cancelled due timelines be not compatible with business strategy in Colombia.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Janssen Research & Development, LLC

Sponsor type

Industry

Conditions

Prostatic Neoplasms

Participants

0

Trials that died the same way

• The Effect of Prophylactic Pre Operative Probiotic Therapy on Endotoxin Levels in Cardiac Surgery Patients
  “Due to delays with logistics and protocol revision not viable to continue.” (57% match in meaning)
• An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
  “Protocol was cancelled by company based on overall efficacy, no safety concern” (56% match in meaning)
• Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.
  “The study was terminated due to additional regulatory requirements that could not be completed within the established academic timeline. As a result, continuation of the study was not feasible.” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.